Myotonic Dystrophy 2

2

Review clinical trials related to Myotonic Dystrophy 2. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Investigating Exercise in Myotonic Dystrophy Type 2 (DM2)

An exercise regimen (PRIME: Proximal Resistance In-House Movement Exercise) has been designed for patients with myotonic dystrophy type 2 (DM2). The hypothesis is that this patient-friendly physical therapist (PT)-guided exercise program associates with improved functional capacity and muscle composition in DM2 in this two-period two-sequence cross-over study. Thus, participant will be randomized to one of the three possible groups. Participants in GROUP A will perform exercise routine virtually under the direct supervision of a physical therapist once a week and another session on their own for the first three months, then they will continue with same exercise routine at home for the last 3 months on their own. Participants in GROUP B will perform exercise routine virtually under the direct supervision of a physical therapist twice a week for the first three months, then they will continue with same exercise routine at home for the last 3 months on their own. Participants in GROUP C will perform exercise routine on their own during the first 3 months, then they will perform exercise routine virtually under the direct supervision of a physical therapist. Each group will include around 8 participants. Duration of the study is 6 months. In addition to exercise sessions, participants will have evaluation of their strength, motor function and muscle composition at three time points: initiation, 3 months and completion of the study at 6 months. Muscle composition will be assessed by electrical impedance myography which is a portable, non-invasive, painless and non-radiation tool that applies a weak high multifrequency electrical current to the examined muscle and allows to obtain information about its composition.

Participants needed: 24
Trial details
Age: 18-70Biological sex: AllType: InterventionalSponsor: Massachusetts General HospitalUpdated: Apr 15, 2026Locations: 1
Eligibility criteria

Patients with genetically confirmed myotonic dystrophy 2 (DM2) who are ≥18 and ≤... [+3]

Subjects younger than 18 years old or older than 70 years old. [+7]

Status: Recruiting

Myotonic Dystrophy Family Registry

The Myotonic Dystrophy Family Registry (MDFR) is an online, patient-entered database that collects information on myotonic dystrophy (DM) to aid researchers in developing new, effective treatments and help identify participants for research studies and clinical trials.

Participants needed: 3,500
Trial details
Biological sex: AllType: ObservationalSponsor: Myotonic Dystrophy FoundationUpdated: Nov 21, 2024Locations: 1Duration: 5 Years
Eligibility criteria

Diagnosed with congenital, juvenile-onset or adult onset DM1 or DM2 (confirmed b...

Not diagnosed with DM, unaffected family members